Latent Raises $80M Series A to Transform the Path from Diagnosis to Treatment Latent, a clinical AI company focused on accelerating access to life-saving medications, has announced the successful close of an $80 million Series A funding round. The round…
ForSight Robotics Achieves Historic First-in-Human Fully Robot-Assisted Cataract Surgery ForSight Robotics has announced a historic milestone in the evolution of eye care: the successful completion of the world’s first fully robot-assisted cataract surgery performed on a human patient. Conducted using…
Lurie Children’s Expands Strategic Partnership with NRC Health to Enhance Consumer Insights and Digital Reputation NRC Health has announced an expanded partnership with Ann & Robert H. Lurie Children’s Hospital of Chicago, reinforcing a shared commitment to advancing patient experience,…
CaryHealth Launches Direct-to-Patient Platform to Transform Access to Natroba™ (Spinosad) CaryHealth, a leading innovator in digital health solutions, has announced the launch of its new direct-to-patient (DTP) platform designed to streamline and enhance patient access to Natroba™ (spinosad). This prescription…
Bridge Dental Group Expands California Presence with New Glendora Partnerships Bridge Dental Group has announced a significant step forward in its national growth strategy with the addition of two well-established practices in Glendora, California—Foothill Family Dental Group and Peak Dental…
Glaukos Highlights Expanding Innovation Portfolio at ASCRS 2026 Annual Meeting Glaukos Corporation, a leader in ophthalmic pharmaceuticals and medical technologies, has announced its participation in the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting, scheduled to take…
Avant Healthcare Professionals Expands “Dream. Become. Inspire.” Nursing Scholarship Worldwide Avant Healthcare Professionals has announced a major expansion of its flagship “Dream. Become. Inspire.” Nursing Scholarship program, extending its reach to more than 100 countries around the world. This move…
Vyome to Present Full Phase 2 Clinical Data on VT-1953 for Malignant Fungating Wounds at AACR 2026 Vyome Holdings, Inc. , a clinical-stage biopharmaceutical company focused on developing novel therapies for immuno-inflammatory and rare conditions, has announced that it will…
Alcon Introduces Clareon® TruPlus IOLs at ASCRS 2026, Expanding Its Advanced Cataract Surgery Portfolio Alcon, a global leader in eye care innovation, has officially launched its latest intraocular lens (IOL), Clareon® TruPlus, in the United States during the annual meeting…
Delcath Systems Secures Key Guideline Recognition for CHEMOSAT in Uveal Melanoma Treatment Delcath Systems, Inc., an interventional oncology company specializing in liver-directed cancer therapies, has announced a significant milestone for its proprietary CHEMOSAT® Hepatic Delivery System for Melphalan. The therapy,…